| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | 0.003 | 0.9 |
| mRNA | Vandetanib | CCLE | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.0033 | 0.9 |
| mRNA | CI-976 | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | AP-24534 | FIMM | pan-cancer | AAC | -0.011 | 0.9 |
| mRNA | BRD-K86535717 | CTRPv2 | pan-cancer | AAC | -0.0052 | 1 |
| mRNA | AT-406 | CTRPv2 | pan-cancer | AAC | 0.0027 | 1 |
| mRNA | BRD-K27986637 | CTRPv2 | pan-cancer | AAC | 0.0046 | 1 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.0021 | 1 |